What is it about?
Countries with large populations and high consumption of turmerics (zaffron) have shown lower numbers of COVID-19 than expected. Curcumin could regulate the expression of ACE-2 - the linking protein for the virus entrance into the human cell - and also inhibit infammatory cytokines which are increased in patients with moderate and severe forms of COVID‐19.
Featured Image
Why is it important?
We have discussed some of the reasons to conduct a randomized controlled trial with Curcumin to treat COVID-19 patients.
Perspectives
As the pandemic impact have been huge and we still don't have an effective drug or vaccine against SARS-CoV-2, we need to find other treatments that can avoid or limit the progression of the disease and the severe forms. Curcumin have been shown many anti-inflammatory mechanisms of action, combining a very high safety profile with relatively low costs.
PhD Marcos Renato de Assis
Faculdade de Medicina de Marília (Famema)
Read the Original
This page is a summary of: Curcumin as a potential treatment for
COVID
‐19, Phytotherapy Research, June 2020, Wiley,
DOI: 10.1002/ptr.6745.
You can read the full text:
Contributors
The following have contributed to this page
